Copper-doped ZnO-ZrO solid solution catalysts were synthesized via co-precipitation for promoting CHOH synthesis via hydrogenation of CO. Various testing methods were applied to investigate the effect of various copper contents on the catalysts. The catalytic performance was evaluated by a fixed bed reactor. XRD, HRTEM and Raman spectra collectively indicated that a ZnO-ZrO solid solution catalyst with 3% Cu had a higher Cu dispersion, while the H-TPR results confirmed that a catalyst with 3% Cu had more Cu active sites under low temperature H pretreatment. When the copper content increased to 5% and 10%, the catalyst showed a better Cu crystallinity and a worse Cu dispersion, which could have a negative effect. Therefore, the CO conversion and methanol yield with a 3% CuZnO-ZrO catalyst at 5 MPa, 250°C and 12 000 ml/(g h) increased by 8.6% and 7.6%, respectively. Moreover, the CHOH selectivity and catalytic stability of the solid solution catalyst were better than those of the traditional CZA catalyst.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265016 | PMC |
http://dx.doi.org/10.1098/rsos.221213 | DOI Listing |
Anal Methods
November 2017
Guangxi Zhuang Autonomous Region Forestry Research Institute, Nanning 530002, China.
1,4-Dihydroxyanthraquinone (1,4-DHAQ, a fluorophore) doped carbon nanotubes@cellulose (1,4-DHAQ-doped CNTs@CL) nanofibrous membranes have been prepared electrospinning and subsequent deacetylation in this work. They have been successfully applied for highly sensitive detection of Cu in aqueous solution. The surface area per unit mass (S/M) ratio of the nanofibrous membranes was enhanced by incorporating the CNTs into cellulose.
View Article and Find Full Text PDFAnal Methods
November 2017
College of Environmental and Chemical Engineering, Nanchang Hangkong University, Nanchang 330063, China.
A novel method was established using a restricted access material combined with a molecularly imprinted polymer (RAM-MIP) as the sorbent material in solid phase extraction (SPE) for clean-up of α-endosulfan, β-endosulfan, endosulfate, endosulfan-ether, endosulfan lactone, heptachlor, heptachlor--epoxide, and heptachlor--epoxide in pork and gas chromatography (GC) for determination. The RAM-MIP was prepared by precipitation polymerization by using endosulfan as the template, methacrylic acid (MAA) as the monomer, glycidyl methacrylate (GMA) as the pro-hydrophilic co-monomer, ethylene glycol dimethacrylate (EGDMA) as the crosslinker, azobisisobutyronitrile (AIBN) as the initiator, and toluene as the porogen. Ultraviolet spectroscopy (UV) and H-nuclear magnetic resonance (H-NMR) analysis verified that MAA interacted specifically with endosulfan in a ratio of 1 : 1 in the pre-polymerization solution.
View Article and Find Full Text PDFNat Commun
January 2025
Department of Mechanical Engineering, Carnegie Mellon University, 5000 Forbes Ave, Pittsburgh, PA, USA.
Effective heat dissipation remains a grand challenge for energy-dense devices and systems. As heterogeneous integration becomes increasingly inevitable in electronics, thermal resistance at interfaces has emerged as a critical bottleneck for thermal management. However, existing thermal interface solutions are constrained by either high thermal resistance or poor reliability.
View Article and Find Full Text PDFJ Immunother Cancer
January 2025
Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Purpose: BMS-986299 is a first-in-class, NOD-, LRR-, and pyrin-domain containing-3 (NLRP3) inflammasome agonist enhancing adaptive immune and T-cell memory responses.
Materials And Methods: This was a phase-I (NCT03444753) study that assessed the safety and tolerability of intra-tumoral BMS-986299 monotherapy (part 1A) and in combination (part 1B) with nivolumab, and ipilimumab in advanced solid tumors. Reported here are single-center results.
J Immunother Cancer
January 2025
Sonata Therapeutics Inc, Watertown, Massachusetts, USA
Cancer immunotherapy-including immune checkpoint inhibition (ICI) and adoptive cell therapy (ACT)-has become a standard, potentially curative treatment for a subset of advanced solid and liquid tumors. However, most patients with cancer do not benefit from the rapidly evolving improvements in the understanding of principal mechanisms determining cancer immune responsiveness (CIR); including patient-specific genetically determined and acquired factors, as well as intrinsic cancer cell biology. Though CIR is multifactorial, fundamental concepts are emerging that should be considered for the design of novel therapeutic strategies and related clinical studies.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!